Fibroblast Growth Factor-2 Enhances Expansion of Human Bone Marrow-Derived Mesenchymal Stromal Cells without Diminishing Their Immunosuppressive Potential
Allogeneic hematopoietic stem cell transplantation is the main curative therapy for many hematologic malignancies. Its potential relies on graft-versus-tumor effects which associate with graft-versus-host disease. Mesenchymal stromal cells (MSCs) possess immunomodulatory properties that make them at...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
SAGE-Hindawi Access to Research
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062108/ |